This inventor holds 1 USPTO granted patent. Top assignee: Roche Sequencing Solutions, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: David L Penkler: Innovator in Next-Generation Sequencing Technologies
Introduction
David L Penkler is a notable inventor based in Fish Hoek, South Africa. He has made significant contributions to the field of molecular biology, particularly in the area of next-generation sequencing technologies. His innovative work has led to the development of a patent that addresses critical challenges in the sequencing process.
Latest Patents
David L Penkler holds a patent titled "Targeted Depletion of Non-Target Library Molecules Using Poison Primers During Target Capture of Next-Generation Sequencing Libraries." This patent represents a significant advancement in improving the accuracy and efficiency of sequencing libraries, which is essential for various applications in genomics.
Career Highlights
David is currently employed at Roche Sequencing Solutions, Inc., where he continues to work on cutting-edge technologies that enhance genomic research. His role at Roche allows him to collaborate with other experts in the field and contribute to the development of innovative solutions.
Collaborations
One of his notable coworkers is Brian Christopher Godwin. Together, they work on projects that aim to push the boundaries of what is possible in sequencing technologies.
Conclusion
David L Penkler's contributions to the field of next-generation sequencing are invaluable. His patent and ongoing work at Roche Sequencing Solutions, Inc. highlight his commitment to advancing genomic research.